Cargando…
Clinical validation of the Cervista(®) high-risk human papillomavirus test in Chinese women from Fujian province: a cross-sectional study
PURPOSE: To estimate the high-risk human papillomavirus (HR-HPV) prevalence in a hospital-based population using the Cervista(®) and to determine the clinical value and significance of Cervista for cervical cancer screening in Fujian Province, China. PATIENTS AND METHODS: In a hospital-based populat...
Autores principales: | Mao, Xiaodan, Ruan, Guanyu, Dong, Binhua, Chen, Lihua, Xu, Shuxia, Lin, Fen, Sun, Pengming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247958/ https://www.ncbi.nlm.nih.gov/pubmed/30532547 http://dx.doi.org/10.2147/TCRM.S179334 |
Ejemplares similares
-
Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China
por: Ruan, Guanyu, et al.
Publicado: (2018) -
Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study
por: Sun, Pengming, et al.
Publicado: (2017) -
Knowledge and Attitudes Regarding HPV and Vaccination Among Chinese Women Aged 20 to 35 Years in Fujian Province: A Cross-Sectional Study
por: Chen, Lihua, et al.
Publicado: (2018) -
PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort
por: Kang, Yafang, et al.
Publicado: (2018) -
Evaluation of Knowledge and Attitude Toward HPV and Vaccination Among Medical Staff, Medical Students, and Community Members in Fujian Province
por: Yu, Chang, et al.
Publicado: (2020)